rs2086452
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_139057.4(ADAMTS17):c.1181+10860C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.543 in 151,738 control chromosomes in the GnomAD database, including 22,910 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.54 ( 22910 hom., cov: 31)
Consequence
ADAMTS17
NM_139057.4 intron
NM_139057.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.145
Publications
10 publications found
Genes affected
ADAMTS17 (HGNC:17109): (ADAM metallopeptidase with thrombospondin type 1 motif 17) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. [provided by RefSeq, May 2016]
ADAMTS17 Gene-Disease associations (from GenCC):
- Weill-Marchesani 4 syndrome, recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.594 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADAMTS17 | ENST00000268070.9 | c.1181+10860C>T | intron_variant | Intron 8 of 21 | 1 | NM_139057.4 | ENSP00000268070.4 | |||
| ADAMTS17 | ENST00000568565.2 | c.1181+10860C>T | intron_variant | Intron 8 of 22 | 5 | ENSP00000456161.2 | ||||
| ADAMTS17 | ENST00000378898.8 | n.862+10860C>T | intron_variant | Intron 7 of 14 | 2 | |||||
| ADAMTS17 | ENST00000559976.1 | n.177+10860C>T | intron_variant | Intron 3 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.543 AC: 82375AN: 151622Hom.: 22886 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
82375
AN:
151622
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.543 AC: 82462AN: 151738Hom.: 22910 Cov.: 31 AF XY: 0.545 AC XY: 40400AN XY: 74144 show subpopulations
GnomAD4 genome
AF:
AC:
82462
AN:
151738
Hom.:
Cov.:
31
AF XY:
AC XY:
40400
AN XY:
74144
show subpopulations
African (AFR)
AF:
AC:
18368
AN:
41374
American (AMR)
AF:
AC:
8658
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
1868
AN:
3472
East Asian (EAS)
AF:
AC:
2495
AN:
5156
South Asian (SAS)
AF:
AC:
1813
AN:
4816
European-Finnish (FIN)
AF:
AC:
6743
AN:
10460
Middle Eastern (MID)
AF:
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40638
AN:
67888
Other (OTH)
AF:
AC:
1161
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1880
3759
5639
7518
9398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1635
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.